Education
About Us
Working with TipRanks
Follow Us
Gerresheimer AG (DE:GXI)
:GXI
GXI Stock Chart & Stats
Day’s Range― - ―
52-Week Range€49.56 - €109.70
Previous CloseN/A
Volume5.61K
Average Volume (3M)297.29K
Market Cap
€1.85B
Enterprise Value€4.83B
Total Cash (Recent Filing)€150.79M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)23.5
Beta0.87
Next Earnings
Jul 10, 2025EPS Estimate
0.85Next Dividend Ex-Date
Jun 06, 2025Dividend Yield2.31%
Share Statistics
EPS (TTM)2.28
Shares Outstanding34,540,000
10 Day Avg. Volume239,846
30 Day Avg. Volume297,293
Financial Highlights & Ratios
PEG Ratio44.70
Price to Book (P/B)N/A
Price to Sales (P/S)1.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€98.10Price Target Upside83.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
EBITDA PerformanceThe EBITDA margin for PPG showed some growth, driven by increased demand for RTF vials and expansion in moulded glass margins.
Revenue GrowthOrder books for tubular glass are robust, suggesting potential incremental revenue growth.
Segment GrowthPrimary Packaging Glass showed 15% sequential quarter-on-quarter growth, leading to a beat at EBITDA driven by a stronger 4Q margin.
Bears Say
Free Cash Flow ConcernsFree cash flow showed a significant negative change, driven by changes in net working capital, raising concerns among investors.
Market SkepticismThe guidance for the rest of the year is viewed with skepticism by investors due to the meaningful acceleration required, especially in free cash flow.
Organic GrowthOrganic growth in the first quarter was lower than expected, showing a decline compared to consensus estimates.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
9.40%
Mutual Funds
0.40% Other Institutional Investors
83.26% Public Companies and
Individual Investors
GXI FAQ
What was Gerresheimer AG’s price range in the past 12 months?
Gerresheimer AG lowest stock price was €49.56 and its highest was €109.70 in the past 12 months.
What is Gerresheimer AG’s market cap?
Gerresheimer AG’s market cap is €1.85B.
When is Gerresheimer AG’s upcoming earnings report date?
Gerresheimer AG’s upcoming earnings report date is Jul 10, 2025 which is in 75 days.
How were Gerresheimer AG’s earnings last quarter?
Gerresheimer AG released its earnings results on Apr 11, 2025. The company reported €0.46 earnings per share for the quarter, beating the consensus estimate of €0.238 by €0.222.
Is Gerresheimer AG overvalued?
According to Wall Street analysts Gerresheimer AG’s price is currently Undervalued.
Does Gerresheimer AG pay dividends?
Gerresheimer AG pays a Annually dividend of €1.25 which represents an annual dividend yield of 2.31%. See more information on Gerresheimer AG dividends here
What is Gerresheimer AG’s EPS estimate?
Gerresheimer AG’s EPS estimate is 0.85.
How many shares outstanding does Gerresheimer AG have?
Gerresheimer AG has 34,540,000 shares outstanding.
What happened to Gerresheimer AG’s price movement after its last earnings report?
Gerresheimer AG reported an EPS of €0.46 in its last earnings report, beating expectations of €0.238. Following the earnings report the stock price went down -1.486%.
Which hedge fund is a major shareholder of Gerresheimer AG?
Currently, no hedge funds are holding shares in DE:GXI
---
Gerresheimer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€98.10 (83.02% Upside)
€98.10 (83.02% Upside)
Insider Transactions
Bought Shares
Worth €75.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.83%
12-Months-Change
Fundamentals
Return on Equity
5.34%
Trailing 12-Months
Asset Growth
39.53%
Trailing 12-Months
Company Description
Gerresheimer AG
Gerresheimer AG provides specialty glass and plastic products to the pharmaceutical and healthcare industry. The firm operates in three segments: plastics and devices, primary packaging glass and advanced technologies. The plastics and devices segment sells products for drug administration, including insulin pens, inhalers, prefillable syringes, and plastic packaging for medications. The primary packaging glass segment produces glass packaging products for drugs and cosmetics, such as injection vials, cartridges, and jars. The advanced technologies segment develops and manufactures intelligent drug delivery systems. Gerresheimer generates the majority of its revenue in Europe, with sales in Germany contributing the largest proportion of any country.
---
GXI Stock 12 Month Forecast
Average Price Target
€98.10
▲(83.02% Upside)
Technical Analysis
Best Analysts Covering GXI
1 Year
1 Year Success Rate
9/18 ratings generated profit
1 Year Average Return
+7.42%
reiterated a buy rating 19 days ago
Copying Sven Olaf Kuerten's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +7.42% per trade.
---